/PRNewswire/ The "Eylea Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This report provides strategists, marketers,.
OSAKA, Japan (BUSINESS WIRE) Santen Pharmaceutical Co., Ltd. (hereafter Santen) announced today that it has signed licensing agreements and an asset transfer agreement with two U.S. companies.Santen has come to an out-licensing agreement with Visiox Pharmaceuticals, Inc. (hereafter Visiox) on the rights to product.
Transaction Includes U.S. and Canadian Commercial Rights to FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, ZERVIATE®, and Non-Prescription Brands FRESHKOTE® and Cationorm® PLUSNASHVILLE, Tenn. (BUSINESS WIRE) $HROW Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of a.
Nicox Provides Second Quarter 2023 Financial and Business Highlights finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.